Hims & Hers Health, Inc. Closes Business Combination and Will Begin Trading on the New York Stock Exchange (press release, January 20, 2021)

Summary

A press release from Hims & Hers Health, Inc. dated January 20, 2021, announcing that it completed its business combination with Oaktree Acquisition Corp., a special purpose acquisition company. The release states that the transaction was approved on January 19, 2021 by Oaktree Acquisition Corp.'s shareholders and that Hims & Hers' Class A common stock will trade on the New York Stock Exchange under the symbol HIMS. It states that the company received proceeds of approximately $279.5 million before transaction expenses, including approximately $204.5 million from the trust account and $75 million from private placement investors, and names its advisors and executive team.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

 Hims & Hers Health, Inc. Closes Business Combination and Will Begin Trading on the New York
                                       Stock Exchange

                         Telehealth leader modernizing consumer-focused healthcare


San Francisco — Janua​ry 20, 2021 — Hims & Hers Health, Inc. (“Hims & Hers”), a multi-specialty telehealth
platform that connects consumers to licensed healthcare professionals, today announced that it has completed
its business combination with Oaktree Acquisition Corp. (NYSE: OAC.U, OAC, OAC WS), a special purpose
acquisition company sponsored by an affiliate of Oaktree Capital Management, L.P. (“Oaktree”). ​The
transaction, which was approved on January 19, 2021 by Oaktree Acquisition Corp.’s shareholders, uniquely
positions Hims & Hers to lead the rapidly-growing telehealth industry, with a focus on improving the customer
experience from start to finish. Beginning January 21, 2​021, Hims & Hers’ shares of Class A common stock will
trade on the New York Stock Exchange (“NYSE”) under the symbol “HIMS” and its warrants will trade on the
NYSE under the symbol “HIMS WS.”

"We drove tremendous progress in 2020 toward our mission of becoming the front door to the healthcare
system," said Andrew Dudum, CEO and co-founder of Hims & Hers. "Today's milestone brings us even closer
to making modern, affordable care accessible to more Americans. By providing a seamless patient experience
combined with proprietary technology, we intend to transform many of healthcare’s most important categories,
including primary care and mental health.”

Hims & Hers will continue to be led by Dudum as CEO alongside its highly experienced executive team,
including Spencer Lee as Chief Financial Officer, Melissa Baird as Chief Operating Officer, Dr. Patrick Carroll
as Chief Medical Officer, and Soleil Teubner Boughton as Chief Legal Officer. In addition, the Company’s
Board of Directors comprises a deep bench of advisors with extensive backgrounds leading and nurturing
fast-growing healthcare businesses and beloved consumer brands.

In October, the Company ​shared​ that it had experienced year-over-year Q3 revenue growth of 91%. Hims &
Hers also ended Q3 2020 with an increase in gross margins — to 76% — as well as growth in net orders and
average order value.

As a result of the business combination, Hims & Hers received proceeds of approximately $279.5 million, prior
to transaction expenses, which includes cash proceeds of approximately $204.5 million from Oaktree
Acquisition Corp.’s trust account and $75 million from private placement (PIPE) investors, including funds
managed by Franklin Templeton and certain Oaktree clients. Leading existing institutional backers of Hims &
Hers include Founders Fund, Forerunner Ventures, IVP, Redpoint Ventures, Thrive Capital, McKesson
Ventures, and Canada Pension Plan Investment Board as well as Cherubic Ventures, Maverick Ventures,
Define Ventures, 8VC, Atomic, NewView Capital, and SV Angel. In addition, Hims & Hers’ current management
and existing equity holders have rolled between 90% and 100% of their equity into the combined company.

LionTree Advisors served as lead financial advisor to Hims & Hers. Citi also served as financial advisor, and
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP served as legal counsel. Credit Suisse and
Deutsche Bank Securities served as capital markets advisors and private placement agents to Oaktree
Acquisition Corp. Deutsche Bank Securities acted as financial advisor to Oaktree Acquisition Corp. Kirkland &
Ellis LLP served as legal counsel to Oaktree Acquisition Corp.

About Hims & Hers
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare
professionals, enabling them to access high-quality medical care for numerous conditions related to mental
health, sexual health, dermatology, primary care, and more. Launched in November 2017, the company also
offers thoughtfully created and curated health and wellness products. With products and services available
across all 50 states and Washington, D.C., Hims & Hers is able to provide all Americans access to quality,
convenient and affordable care. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack
Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about
Hims & Hers, please visit forhims.com and forhers.com.


Forward-Looking Statements

Certain statements in this press release may be considered forward-looking statements. Forward-looking
statements generally relate to future events or Hims & Hers’ future financial or operating performance. For
example, statements about the benefits of the proposed business combination, the competitive
environment, and the expected future performance, growth and market opportunities of Hims & Hers are
forward-looking statements. In some cases, you can identify forward-looking statements by terminology
such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or
“continue”, or the negatives of these terms or variations of them or similar terminology. Such
forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual
results to differ materially from those expressed or implied by such forward-looking statements. These
forward-looking statements are based upon estimates and assumptions that, while considered reasonable
by Hims & Hers and its management, are inherently uncertain. Factors that may cause actual results to
differ materially from current expectations include, but are not limited to: the ability to recognize the
anticipated benefits of the proposed business combination, which may be affected by, among other
things, competition, the ability of Hims & Hers to grow and manage growth profitably, maintain
relationships with customers and suppliers and retain its management and key employees; costs related
to the proposed business combination; changes in applicable laws or regulations; the possibility that Hims
& Hers may be adversely affected by other economic, business, and/or competitive factors; the limited
operating history of Hims & Hers; the Hims & Hers business is subject to significant governmental
regulation; the Hims & Hers business may not successfully expand into other markets, including womens’
health; and the potential adverse effects of the ongoing COVID-19 pandemic. Nothing in this press
release should be regarded as a representation by any person that the forward-looking statements set
forth herein will be achieved or that any of the contemplated results of such forward-looking statements
will be achieved. You should not place undue reliance on forward-looking statements, which speak only
as of the date they are made. Hims & Hers does not undertake any duty to update these forward-looking
statements.

Contacts:

Investor Relations

Hims & Hers
Bob East or Jordan Kohnstam
Westwicke, an ICR company
HIMSIR@westwicke.com
(443) 213-0500

Oaktree Acquisition Corp.
infoOAC1@oaktreeacquisitioncorp.com

Media Relations

Hims & Hers
Press@forhims.com

Sean Leous
Westwicke, an ICR company
HIMSPR@westwicke.com
(646) 866-4012

Oaktree Acquisition Corp.
mediainquiries@oaktreecapital.com


File and source

File

hims-close-pdf-2021-01-21.pdf

Size

104,391 bytes

SHA-256

5b0af366178bfd159371d58ff0a65c691550fbbd7e51a308537721d498faf858

Our copy

hims-close-pdf-2021-01-21.pdf

Original

s27.q4cdn.com